Literature DB >> 15816800

Efficacy of quetiapine in generalized social anxiety disorder: results from an open-label study.

Sara I J Schutters, Harold J G M van Megen, Herman G M Westenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15816800     DOI： 10.4088/jcp.v66n0420b

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN： 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  7 in total

1.  Dopamine transporter binding in social anxiety disorder: the effect of treatment with escitalopram.

Authors:  J M Warwick; P D Carey; N Cassimjee; C Lochner; S Hemmings; H Moolman-Smook; E Beetge; P Dupont; D J Stein
Journal:  Metab Brain Dis       Date:  2012-02-16       Impact factor: 3.584

2.  Pharmacotherapy for Anxiety Disorders: From First-Line Options to Treatment Resistance.

Authors:  Andrew J Melaragno
Journal:  Focus (Am Psychiatr Publ)       Date:  2021-06-17

3.  Dopamine transporters, D2 receptors, and dopamine release in generalized social anxiety disorder.

Authors:  Franklin R Schneier; Anissa Abi-Dargham; Diana Martinez; Mark Slifstein; Dah-Ren Hwang; Michael R Liebowitz; Marc Laruelle
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

Review 4.  The Place of Antipsychotics in the Therapy of Anxiety Disorders and Obsessive-Compulsive Disorders.

Authors:  Baptiste Pignon; Chloé Tezenas du Montcel; Louise Carton; Antoine Pelissolo
Journal:  Curr Psychiatry Rep       Date:  2017-11-07       Impact factor: 5.285

Review 5.  Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders.

Authors:  Martin A Katzman; Pierre Bleau; Pierre Blier; Pratap Chokka; Kevin Kjernisted; Michael Van Ameringen; Martin M Antony; Stéphane Bouchard; Alain Brunet; Martine Flament; Sophie Grigoriadis; Sandra Mendlowitz; Kieron O'Connor; Kiran Rabheru; Peggy M A Richter; Melisa Robichaud; John R Walker
Journal:  BMC Psychiatry       Date:  2014-07-02       Impact factor: 3.630

6.  Atypical antipsychotic quetiapine in the management of severe refractory functional gastrointestinal disorders.

Authors:  Madhusudan Grover; Spencer D Dorn; Stephan R Weinland; Christine B Dalton; Bradley N Gaynes; Douglas A Drossman
Journal:  Dig Dis Sci       Date:  2009-02-26       Impact factor: 3.199

7.  Quetiapine fumarate augmentation for patients with a primary anxiety disorder or a mood disorder: a pilot study.

Authors:  Yi-Chih Chen; Chih-Ken Chen; Liang-Jen Wang
Journal:  BMC Psychiatry       Date:  2012-09-29       Impact factor: 3.630
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.